Efficacy of lung cancer screening appears to increase with prolonged intervention: results from the MILD trial and a meta-analysis

Affiliations

¹ Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia.
² Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
³ Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy. Electronic address: carlo.lavecchia@unimi.it.
⁴ Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USA; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Free article

Editorial

M Rota et al. Ann Oncol. 2019.

Free article

. 2019 Jul 1;30(7):1040-1043.

doi: 10.1093/annonc/mdz145.

¹ Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia.
² Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
³ Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy. Electronic address: carlo.lavecchia@unimi.it.
⁴ Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USA; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

No abstract available

Comment on

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchianò A. Pastorino U, et al. Ann Oncol. 2019 Jul 1;30(7):1162-1169. doi: 10.1093/annonc/mdz117. Ann Oncol. 2019. PMID: 30937431 Free PMC article. Clinical Trial.